AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05596643 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: blood pressure response to standing
Description: clinical test to detect sympathetic dysfunction
Study NCT05596643 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: blood pressure response to sustained handgrip test
Description: clinical test to detect sympathetic dysfunction
Study NCT05596643 — intervention group
Intervention type: OTHER
Intervention: Hospital anxiety and depression scale
Description: Standardized questionnaire to investigate the depression and anxiety
Study NCT05596643 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Fibromyalgia rapid screening tool
Description: Standardized questionnaire to determine the presence of fibromyalgia
Study NCT05596643 — intervention group
Intervention type: OTHER
Intervention: Familial Mediterranean Fever Quality of life scale
Description: Standardized questionnaire to investigate the quality of life in Familial Mediterranean Fever patients
Study NCT05596643 — intervention group
Intervention type: OTHER
Intervention: Jenkins Sleep Evaluation Scale
Description: Standardized questionnaire to investigate the sleep quality and disturbance
Study NCT05596643 — intervention group
Intervention type: OTHER
Intervention: The Fatigue Severity Scale
Description: Standardized questionnaire to investigate the fatigue severity
Study NCT05599009 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: remote ischemic conditioning
Description: Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min re-perfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 200 mmHg. All patients underwent dynamic cerebral autoregulation before treatment, immediately after treatment, 6 hours after treatment and 24 hours after treatment.
Study NCT05599009 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: sham remote ischemic conditioning
Description: Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min re-perfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 60 mmHg. All patients underwent dynamic cerebral autoregulation before treatment, immediately after treatment, 6 hours after treatment and 24 hours after treatment.
Study NCT04843033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SH3809 tablet
Description: Starting dose 2mg,oral administered once daily. If tolerated subsequent cohorts will test increasing doses (4mg,6mg,8mg,10mg,12mg) of SH3809.
Study NCT06495788 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High-intensity laser therapy (HILT)
Description: * Pulsed high-intensity laser therapy (HILT) will be applied 3 sessions per week for 8 weeks with pulsed emission (1064 nm), very high peak power (3 kW), a short duration (120-150 ms), and low frequency (10-40 Hz).The probe is fixed vertically at 90° to the most painful points while the patients sit on a chair and wear safety eyewear.~* Conventional treatment ( 3 days per week for 8 weeks).: in the form of~* Hot pad: It will be used over the temporomandibular joint (TMJ) for 5 minutes at the beginning of each session.~* Ultrasound therapy (US): it will be applied over the TMJ with pulsed intensity of 1.0 W/cm2 at a 1MHz frequency for 5 min/session.~* TENS: one electrode is placed over the TMJ and the other just above the mandibular angle. it will be applied with a low frequency of 50 HZ, tolerable intensity for 15 minutes.~* Exercise therapy: anterior, medial and lateral glide of the mandible. Each glide will be done 10-15 repetitions, 5-6 times in a session, 10 minutes as a total.
Study NCT06495788 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: placebo high-intensity laser therapy
Description: The same treatment procedure will be applied in the placebo group as in the experimental group, but the laser device is turned off during applications, in addition to the conventional treatment in the form of hot pad, US, TENS, and exercise therapy.
Study NCT06286839 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Description: Cannabidiol (CBD), a non-psychoactive component of Cannabis sativa L.
Study NCT05729633 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robot mediated upper limb therapy
Description: The OR is classified as a Class A device with the Health Sciences Authority. The OR is capable of both delivering RMIT as well as RMTT. It can provide zero, partial, or full assistance to the patient to complete the movement or task. Its teach-and-follow mode allows a movement to be performed by the therapist, with the device then replaying the movement at either zero, partial, or full assistance, for the patient.~Impairment oriented training will focus on the following movements:~1. Diagonal movement~2. Shoulder abduction~3. Shoulder adduction~4. Shoulder flexion~5. Shoulder extension~6. Elbow flexion~7. Elbow extension~Task-specific training will focus on the following activities:~1. Picking up a cup/glass by the side and drink~2. Brushing hair~3. Cleaning unaffected upper limb (hand to arm)~4. Wiping table~5. Wiping wall~6. Sliding card on table to a designated location~7. Clipping a clothe peg
Study NCT05147454 — intervention group
Intervention type: OTHER
Intervention: Quantitative Sensory Testing
Description: Non-invasive assessment of Sensory Profile
Study NCT06207825 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Test images and videos
Description: A set of test images and videos will be collected prospectively from other subjects, according to the eligibility criteria, followed by random allocation of computer-generated sequence.
Study NCT04744844 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: blastocoel fluid biopsy
Description: In the present study, blastocoel fluid biopsy (BF-biopsy) and collapse will be performed using a microinjection pipette similar to that used to perform ICSI. The pipette will be pushed gently through the zona pellucida and TE, and up to 90% of the BF will be aspirated.
Study NCT04744844 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: blastocoel fluid biopsy
Description: In the present study, blastocoel fluid biopsy (BF-biopsy) and collapse will be performed using a microinjection pipette similar to that used to perform ICSI. The pipette will be pushed gently through the zona pellucida and TE, and up to 90% of the BF will be aspirated.
Study NCT06280469 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Single-Balloon Enteroscopy
Description: The inflated balloon is supposed to fix the intestine to the endoscope system.Pushing the endoscope deeper into the small bowel with the balloon and enteroscope.
Study NCT04622384 — intervention group
Intervention type: OTHER
Intervention: Dialysis weaning
Description: Dialysis weaning as planned by the attending ICU-physician.
Study NCT06370143 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: The questionnaire on clinical, environmental, lifestyle, and dietary risk factors will be administered
Study NCT06480396 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: High-intensity radiological surveillance
Description: The standard approach to surveillance imaging will be contrasted CT (IV and oral contrast) of the chest, abdomen and pelvis. All patients require radiological assessment of the chest, abdomen and pelvis at each surveillance round. Tolerance will be given in the protocol for selected patients where CT is not suitable to receive alternative imaging such as MRI or combination of MRI and CT. Uncontrasted CT imaging is permissible where renal toxicity or allergy from intravenous contrast is of concern. The use of plain radiography is not permitted as an alternative to CT imaging of the chest.
Study NCT06480396 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Lower-intensity radiological surveillance
Description: The standard approach to surveillance imaging will be contrasted CT (IV and oral contrast) of the chest, abdomen and pelvis. All patients require radiological assessment of the chest, abdomen and pelvis at each surveillance round. Tolerance will be given in the protocol for selected patients where CT is not suitable to receive alternative imaging such as MRI or combination of MRI and CT. Uncontrasted CT imaging is permissible where renal toxicity or allergy from intravenous contrast is of concern. The use of plain radiography is not permitted as an alternative to CT imaging of the chest.
Study NCT05294237 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Happy program
Description: The Happy program consists of handball specific warm-up components and resistance training components and will be available online.
Study NCT05294237 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Happy program
Description: The Happy program consists of handball specific warm-up components and resistance training components and will be available online.
Study NCT05294237 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Support
Description: The support consists of a coach workshop at the beginning of the season and the opportunity for additional support for the coaches throughout the season.
Study NCT05047705 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Distress Tolerance Skills Training
Description: Individuals with TS will receive distress tolerance skill training. Therapeutic skill training will consist of 4 weekly 1-hour sessions. Skill training will occur either in-person or remotely via videoconferencing software. Sessions will focus on building participants' distress tolerance skills with strategies drawn from third-wave CBT.
Study NCT06152874 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: consumption of glucose solution 1
Description: glucose solution prepared dissolving 55 g of monohydrate glucose powder in 250 mL of water
Study NCT06152874 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: consumption of glucose solution 2
Description: glucose solution prepared dissolving 55 g of monohydrate glucose powder in 250 mL of water
Study NCT06152874 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: consumption of Bread A and oral processing
Description: bread made with 95% durum wheat fine semolina (\< 400 micrometer) + 5% of gluten + 1.2% of yeast + 1% of salt + 59%of water) (portion corresponding to 50 g available carbohydrates) + 250 mL water
Study NCT06152874 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: consumption of Bread B and oral processing
Description: bread made with 80% durum wheat fine semolina (\< 400micrometer) + 20% of gluten+ 1.2% of yeast + 1% of salt + 59%of water (portion corresponding to 50g available carbohydrates) +250 mL water
Study NCT06152874 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: consumption of Bread C and oral processing
Description: bread made with 80% durum wheat coarse semolina (> 500micrometer)+ 20% of gluten+ 1.2% of yeast + 1% of salt + 59%of water (portion corresponding to 50g available carbohydrates) +250 mL water
Study NCT06574958 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD38/CS1 injection
Description: Dosage form and specification: injection, 40mL/ dose, according to the number of positive cells 1×106/kg Properties: Colorless or slightly light white clear liquid Prescription composition: CD38/CS1 CAR T cells, 2.5% human blood albumin, 0.9% sodium chloride injection.~Administration mode: intravenous injection Storage condition: 2-8℃ for 8h Mechanism of action :38WP as a dual-target CAR T cell therapy, compared with single-target CAR T cell therapy, its advantage is that it can reduce antigen escape of tumor cells.
Study NCT06574945 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: intravenous injection of propofol only
Description: Propofol was administered intravenously 2 mg/kg
Study NCT06574945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intravenous injection of propofol +esketamine
Description: intravenous injection of 0.5 mg/kg ESK followed by 1.5 mg/kg of propofol or intravenous injection of 0.25 mg/kg ESK followed by 1.5 mg/kg of propofol
Study NCT06240273 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Corn silk powder
Description: Corn silk (CS) is abundant in phenolic compounds, especially flavonoids. It also contains proteins, vitamins, carbohydrates, calcium, potassium, magnesium, sodium salts, volatile oils, sterols like sitosterol and stigmasterol, alkaloids, and saponins. Numerous studies have explored the pharmacological activities associated with CS.
Study NCT04601519 — intervention group
Intervention type: OTHER
Intervention: Cross-sectional observational study
Description: Online questionnaire on the impact of type 1 diabetes on sleep quality
Study NCT04725955 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Enriched wheat bread
Description: Either 50g of glucose dissolved in 250mL water or white wheat bread or wheat bread enriched with 5mg a-cyclodextrin or wheat bread enriched with a 5mg mixture of a-cyclodextrin and encapsulated hydroxytyrosol (per 50g of available carbohydrates).
Study NCT04725955 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enriched wheat bread
Description: Either 50g of glucose dissolved in 250mL water or white wheat bread or wheat bread enriched with 5mg a-cyclodextrin or wheat bread enriched with a 5mg mixture of a-cyclodextrin and encapsulated hydroxytyrosol (per 50g of available carbohydrates).
Study NCT04725955 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enriched wheat bread
Description: Either 50g of glucose dissolved in 250mL water or white wheat bread or wheat bread enriched with 5mg a-cyclodextrin or wheat bread enriched with a 5mg mixture of a-cyclodextrin and encapsulated hydroxytyrosol (per 50g of available carbohydrates).
Study NCT05896033 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Non-Menthol Cigarettes
Description: Ppts will be randomly assigned to a group that receives non-menthol cigarettes
Study NCT05896033 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tobacco Flavored E-cigarettes
Description: Ppts will be randomly assigned to a group that receives tobacco flavored e-cigarettes
Study NCT05896033 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Menthol Cigarettes
Description: Ppts will be randomly assigned to a group that receives menthol flavored cigarettes
Study NCT05896033 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Menthol Flavored E-cigarettes
Description: Ppts will be randomly assigned to a group that receives menthol flavored e-cigarettes
Study NCT04920396 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: E>Eye IRPL
Description: Regulated intense pulsed light therapy
Study NCT05382260 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Listening to music
Description: After 5 minutes baseline, participants would listen to three kinds of music with 3 minutes washout and another 5 minutes baseline in the end, while EEG would record their cortical activity. And the order of the three kinds of music is random.
Study NCT05382260 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Listening to music
Description: After 5 minutes baseline, participants would listen to three kinds of music with 3 minutes washout and another 5 minutes baseline in the end, while EEG would record their cortical activity. And the order of the three kinds of music is random.
Study NCT06150651 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CAR T-cell therapy
Description: 1x10\^6 cells/kg CD-19 CAR-T cells
Study NCT05654896 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ceftriaxone Sodium
Description: Antibiotic will be administered prophylactically for TACE
Study NCT04565171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Yimitasvir Phosphate Capsule
Description: DAG181 100 mg (100 mg Capsule) administered orally
Study NCT04917133 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adapted Physical Activity program
Description: classic 4-week rehabilitation program (standard care) + 6 APA workshops per week with collective care
Study NCT04917133 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: classic 4-week rehabilitation program (standard care)
Study NCT04897984 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Liver-enriched antimicrobial peptide 2
Description: IV infusion of LEAP2, 2 hours
Study NCT06056375 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Reclaiming Nature Intervention
Description: The purpose of the community intervention is to prevent health disparities in Black, Latinx, Pilipinx, and Pacific Islander communities of San Francisco, California.
Study NCT06579820 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: tubular bandage
Description: The experimental group consisted of the group in which a tubular bandage was applied over the PIC, which was routinely applied.
Study NCT06579482 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aesculus hippocastanum, and associations
Description: combination product
Study NCT06579482 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aesculus hippocastanum, and associations
Description: combination product
Study NCT06393101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BRC-002
Description: BRC-002 is a non-scheduled cannabidiolic (CBD) formulation (\<.3% THC). The cannabinoids in BRC-002 are naturally biosynthesized within the Cannabis sativa L. plant as acidic forms of CBD (cannabidiolic acid; CBDA), THC (tetrahydrocannabinolic acid; THCA) and other minor cannabinoids.
Study NCT06393101 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: BRC-002 Placebo
Description: Oral solution of mono-, di-, and triglycerides
Study NCT05902962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VP-001
Description: Phase 1 open-label, single arm dose escalation study of VP-001 in participants with genetically confirmed PRPF31 mutation-associated retinal dystrophy
Study NCT05646121 — intervention group
Intervention type: DEVICE
Intervention: Suprasorb® A + Ag wound dressing and rope
Description: Suprasorb® A + Ag Antimicrobial Calcium Alginate Wound Dressings / Packing Rope are soft, conformable wound coverings with a high mannuronic acid content (mass per unit area ≥100 g/m2). The silver impregnated calcium alginate fibres react with wound exudate or blood to form a gel which creates a moist wound environment. The silver contained in the wound dressing has broad antimicrobial activity, including against MRSA and VRE. Antimicrobial action (>3 log steps) associated with the ionic silver from the silver alginate fibres (1.5%) is observed in vitro after just 24 h and this remains stable for up to seven days
Study NCT06460974 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: stress ball
Description: A stress ball was applied to the patients in the during chemotherapy treatment.
Study NCT06380465 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The water extract of Biang variety purple sweet potato
Description: Purple sweet potato extract is a mixture of water and Biang variety of purple sweet potato puree, enhanced with a touch of flavoring
Study NCT06380465 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: The water extract of Biang variety purple sweet potato
Description: Purple sweet potato extract is a mixture of water and Biang variety of purple sweet potato puree, enhanced with a touch of flavoring
Study NCT04406948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MGCND00EP1
Description: Patients will take cannabis oil during the study
Study NCT04406948 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patient will take carrier oil during the study
Study NCT04406948 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ECG
Description: A standard 12-lead ECG will be recorded using digital ECG recording equipment provided to the investigational site. The ECG has to be performed prior to laboratory samplings at time points indicated in the Schedule of Assessments.~The ECG recording will be reviewed by investigator and case of need consultation with cardiologist will be performed. The investigator has the final decision on the clinical significance of the ECG results.
Study NCT04406948 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: ECG
Description: A standard 12-lead ECG will be recorded using digital ECG recording equipment provided to the investigational site. The ECG has to be performed prior to laboratory samplings at time points indicated in the Schedule of Assessments.~The ECG recording will be reviewed by investigator and case of need consultation with cardiologist will be performed. The investigator has the final decision on the clinical significance of the ECG results.
Study NCT04406948 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: EEG
Description: An EEG is an electrophysiological monitoring method that records the electrical activity and measures voltage fluctuations resulting from ionic current within the neurons of the brain. In clinical contexts, EEG refers to the recording of the brain's spontaneous electrical activity over a period of time.
Study NCT04920396 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Warm compress
Description: Fabric mask with anti-bacterial coating filled with BodyBeads® heated in a microwave for 30 seconds before application over the eyes for 5 minutes
Study NCT04406948 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: EEG
Description: An EEG is an electrophysiological monitoring method that records the electrical activity and measures voltage fluctuations resulting from ionic current within the neurons of the brain. In clinical contexts, EEG refers to the recording of the brain's spontaneous electrical activity over a period of time.
Study NCT04406948 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood and urine collection
Description: safety blood tests - hematology\\blood count and biochemistry standard blood tests urinalysis - urine test analysis